La FDA ha eliminado la advertencia de recuadro negro de las etiquetas de algunos medicamentos para la terapia hormonal de la menopausia: esto es lo que realmente significa
On November 10, 2025, the U.S. FDA announced it is initiating removal of the boxed (“black box”) warnings from menopause hormone therapy (MHT) product labeling — specifically removing class-wide references to cardiovascular disease, breast cancer, and “probable dementia.” What changed (and what didn’t) What the FDA is removing from boxed warnings (for menopausal hormone therapy […]